Procter & Gamble Company (The) $PG is Bahl & Gaynor Inc.'s Largest Position

Key Points

• Bahl & Gaynor Inc. increased its stake in Procter & Gamble by 2.8% in the first quarter, making it the firm's largest holding at approximately 3.7% of its investment portfolio.
• Procter & Gamble reported $1.48 earnings per share for the latest quarter, exceeding analyst expectations, with a revenue of $20.89 billion.
• The company recently declared a quarterly dividend of $1.0568 per share, translating to an annualized dividend yield of 2.7%.

Bahl & Gaynor Inc. grew its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 2.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,277,991 shares of the company's stock after acquiring an additional 116,907 shares during the quarter. Procter & Gamble comprises approximately 3.7% of Bahl & Gaynor Inc.'s investment portfolio, making the stock its largest holding. Bahl & Gaynor Inc. owned about 0.18% of Procter & Gamble worth $729,055,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the stock. Nuveen LLC acquired a new position in Procter & Gamble in the 1st quarter worth approximately $1,954,941,000. GAMMA Investing LLC boosted its position in Procter & Gamble by 20,758.5% in the 1st quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock worth $1,355,087,000 after purchasing an additional 7,913,335 shares in the last quarter. Northern Trust Corp lifted its position in shares of Procter & Gamble by 10.1% during the 4th quarter. Northern Trust Corp now owns 29,395,208 shares of the company's stock valued at $4,928,107,000 after buying an additional 2,703,757 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after buying an additional 2,466,308 shares in the last quarter. Finally, Invesco Ltd. lifted its position in shares of Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock valued at $2,299,580,000 after buying an additional 2,228,151 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on PG shares. UBS Group set a $180.00 price objective on Procter & Gamble and gave the company a "buy" rating in a report on Wednesday, July 30th. Piper Sandler raised their price objective on Procter & Gamble from $160.00 to $164.00 and gave the company a "neutral" rating in a report on Monday, May 5th. Morgan Stanley set a $180.00 price objective on Procter & Gamble and gave the company an "overweight" rating in a report on Friday, April 25th. Evercore ISI restated an "in-line" rating and issued a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Finally, Truist Financial decreased their price objective on Procter & Gamble from $185.00 to $180.00 and set a "buy" rating on the stock in a report on Friday, April 25th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $175.94.

Procter & Gamble Stock Down 0.1%

Shares of NYSE:PG opened at $158.5140 on Friday. The business has a 50-day moving average price of $156.79 and a 200 day moving average price of $162.97. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The company has a market capitalization of $371.30 billion, a price-to-earnings ratio of 24.35, a PEG ratio of 4.19 and a beta of 0.37. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. The firm had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company's quarterly revenue was up 1.7% on a year-over-year basis. During the same period last year, the company earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Sell-side analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were given a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is presently 64.98%.

Insider Activity

In related news, CAO Matthew W. Janzaruk sold 319 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $50,169.13. Following the completion of the sale, the chief accounting officer directly owned 1,704 shares of the company's stock, valued at approximately $267,988.08. This trade represents a 15.77% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jennifer L. Davis sold 8,596 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,351,892.92. Following the sale, the chief executive officer directly owned 64,991 shares of the company's stock, valued at $10,221,134.57. The trade was a 11.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 119,181 shares of company stock worth $18,761,172. 0.18% of the stock is currently owned by corporate insiders.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.